Product Information
KRSR selectively enhanced heparan sulfate-mediated osteoblast adhesion mechanisms. Elucidating such peptide sequence is of importance to the field of bone-cell/tissue engineering as well as to the design of proactive dental/orthopedic biomaterials. Note: Uses of this peptide are covered by U.S. Patent No. 6,262,017 B1 owned by Rensselaer Polytechnic Institute (RPI) located in Troy, New York, U.S.A. RPI authorizes purchasers of 5 grams or less per year to use this peptide for research purposes only. Other purchasers must have a written licence from RPI.
Chemical properties
Technical inquiry about: 01-4029131 Osteoblast-Adhesive Peptide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
